ATE231874T1 - Antivirale purin-derivate - Google Patents

Antivirale purin-derivate

Info

Publication number
ATE231874T1
ATE231874T1 AT99949151T AT99949151T ATE231874T1 AT E231874 T1 ATE231874 T1 AT E231874T1 AT 99949151 T AT99949151 T AT 99949151T AT 99949151 T AT99949151 T AT 99949151T AT E231874 T1 ATE231874 T1 AT E231874T1
Authority
AT
Austria
Prior art keywords
purine derivatives
antiviral purine
antiviral
derivatives
purine
Prior art date
Application number
AT99949151T
Other languages
English (en)
Inventor
Christopher Mcguigan
Jan Balzarini
Original Assignee
Univ Cardiff
Rega Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cardiff, Rega Foundation filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE231874T1 publication Critical patent/ATE231874T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99949151T 1998-09-28 1999-09-27 Antivirale purin-derivate ATE231874T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9821058.6A GB9821058D0 (en) 1998-09-28 1998-09-28 Chemical compound
PCT/GB1999/003207 WO2000018775A1 (en) 1998-09-28 1999-09-27 Antiviral purine derivatives

Publications (1)

Publication Number Publication Date
ATE231874T1 true ATE231874T1 (de) 2003-02-15

Family

ID=10839578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99949151T ATE231874T1 (de) 1998-09-28 1999-09-27 Antivirale purin-derivate

Country Status (31)

Country Link
US (1) US6638919B2 (de)
EP (1) EP1117669B1 (de)
JP (1) JP2002525374A (de)
KR (1) KR20010085855A (de)
CN (1) CN1328565A (de)
AR (1) AR042368A1 (de)
AT (1) ATE231874T1 (de)
AU (1) AU762757B2 (de)
BR (1) BR9914097A (de)
CA (1) CA2345672A1 (de)
DE (1) DE69905181T2 (de)
DK (1) DK1117669T3 (de)
ES (1) ES2192081T3 (de)
GB (1) GB9821058D0 (de)
GC (1) GC0000174A (de)
GT (1) GT199900166A (de)
HU (1) HUP0103641A3 (de)
IL (1) IL141959A0 (de)
MA (1) MA26694A1 (de)
MY (1) MY121839A (de)
NO (1) NO20011198L (de)
NZ (1) NZ510506A (de)
PA (1) PA8483101A1 (de)
PE (1) PE20001072A1 (de)
PL (1) PL346905A1 (de)
PT (1) PT1117669E (de)
TN (1) TNSN99183A1 (de)
TR (1) TR200100864T2 (de)
TW (1) TWI243176B (de)
WO (1) WO2000018775A1 (de)
ZA (1) ZA200102170B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2362662A1 (en) * 1999-02-12 2000-08-17 Glaxo Group Limited Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
PE20010915A1 (es) * 1999-12-10 2001-09-29 Glaxo Group Ltd Analogos de (1s, cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales
WO2001042255A1 (en) * 1999-12-10 2001-06-14 Glaxo Group Limited (1R,CIS)-4-(4-AMINO-7H-PYRROLO'2,3-I(D) ! PYRIMIDINE-7-YL)-2-CYCLOPENTENE-1-METHANOL DERIVATIVES AS ANTIVIRAL
US20020119443A1 (en) 2000-07-21 2002-08-29 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
US8716548B2 (en) 2002-02-20 2014-05-06 The Procter & Gamble Company Disposable absorbent article designed to facilitate an easy change
US20030158532A1 (en) 2002-02-20 2003-08-21 Magee Luke R. Disposable absorbent article designed to facilitate an easy intuitive change
EP1572097A4 (de) 2002-09-30 2010-02-17 Smithkline Beecham Corp Nucleosid-derivate zur behandlung von infektionen mit dem hepatitis c-virus
US7094768B2 (en) 2002-09-30 2006-08-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
LT1576138T (lt) 2002-11-15 2017-06-26 Idenix Pharmaceuticals Llc 2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
CA2571079A1 (en) * 2004-06-24 2006-02-02 Merck & Co., Inc. Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
WO2006011955A1 (en) * 2004-06-30 2006-02-02 Eli Lilly And Company 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
PL217694B1 (pl) 2010-10-19 2014-08-29 Inst Chemii Bioorg Polskiej Akademii Nauk Analog nukleotydu, sposób otrzymywania analogu nukleotydu, zastosowanie analogu nukleotydu, pro-nukleotyd antywirusowy, kompozycja farmaceutyczna
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
AR088441A1 (es) 2011-09-12 2014-06-11 Idenix Pharmaceuticals Inc Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales
EP2709613B2 (de) 2011-09-16 2020-08-12 Gilead Pharmasset LLC Verfahren zur behandlung von hcv
US8507460B2 (en) 2011-10-14 2013-08-13 Idenix Pharmaceuticals, Inc. Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
JP6165848B2 (ja) 2012-05-22 2017-07-19 イデニク ファーマシューティカルズ エルエルシー 肝疾患のためのｄ−アミノ酸化合物
WO2013177188A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphoramidate prodrugs for hcv infection
US9296778B2 (en) 2012-05-22 2016-03-29 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphate prodrugs for HCV infection
MX2014014323A (es) 2012-05-25 2015-02-12 Janssen R & D Ireland Nucleosidos de espirooxetano de uracilo.
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
WO2014052638A1 (en) 2012-09-27 2014-04-03 Idenix Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
EP2906579B1 (de) 2012-10-08 2018-04-18 Idenix Pharmaceuticals LLC. 2'-chlor-nukleosidanaloga für hcv-infektion
US10723754B2 (en) 2012-10-22 2020-07-28 Idenix Pharmaceuticals Llc 2′,4′-bridged nucleosides for HCV infection
EP2935304A1 (de) 2012-12-19 2015-10-28 IDENIX Pharmaceuticals, Inc. 4'-fluor-nukleoside zur behandlung von hcv
EP2950786B1 (de) 2013-01-31 2019-11-27 Gilead Pharmasset LLC Kombinationsformulierung zweier antiviraler verbindungen
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
WO2014137926A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. 3'-deoxy nucleosides for the treatment of hcv
WO2014160484A1 (en) 2013-03-13 2014-10-02 Idenix Pharmaceuticals, Inc. Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
EP2981542B1 (de) 2013-04-01 2021-09-15 Idenix Pharmaceuticals LLC 2',4'-fluor-nukleoside zur behandlung von hcv
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
WO2015017713A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
US10202411B2 (en) 2014-04-16 2019-02-12 Idenix Pharmaceuticals Llc 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
WO2016134058A1 (en) 2015-02-18 2016-08-25 Abbvie Inc. Combinations useful to treat hepatitis c virus
CN113444046B (zh) * 2016-07-20 2023-10-27 纳莹(上海)生物科技有限公司 一种荧光探针及其制备方法和用途
WO2018033593A1 (en) * 2016-08-19 2018-02-22 Sandoz Ag Sofosbuvir derivatives for the treatment of hepatitis c
RU2659388C1 (ru) * 2017-02-28 2018-07-02 Васильевич Иващенко Александр Нуклеотиды, включающие N-[(S)-1-циклобутоксикарбонил]фосфорамидатный фрагмент, их аналоги и их применение
TW202019941A (zh) 2018-07-27 2020-06-01 日商富士軟片股份有限公司 環丁基嘌呤衍生物或其鹽
WO2020022486A1 (ja) * 2018-07-27 2020-01-30 富士フイルム株式会社 シクロペンテニルプリン誘導体またはその塩

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88518A (en) 1987-11-30 1994-02-27 Beecham Group Plc 3-(phosphoryl methoxyethoxy) -purine derivatives, their preparation and pharmaceutical compositions containing them
CA2001715C (en) * 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
EP0468119A1 (de) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Neue Carbocyclische Analoge einiger Nukleoside
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
EP0618214A1 (de) 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Ungesättigte Phosphonatderivate Purinen und Pyrimidinen
EP0719273B1 (de) 1993-09-17 2010-11-03 Gilead Sciences, Inc. Nukleotidanaloge
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
BR9714349A (pt) 1996-10-16 2000-11-14 Icn Pharmaceuticals L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos

Also Published As

Publication number Publication date
TWI243176B (en) 2005-11-11
EP1117669A1 (de) 2001-07-25
NO20011198D0 (no) 2001-03-08
KR20010085855A (ko) 2001-09-07
US6638919B2 (en) 2003-10-28
ZA200102170B (en) 2002-03-15
PA8483101A1 (es) 2000-09-29
WO2000018775A1 (en) 2000-04-06
NZ510506A (en) 2003-08-29
PL346905A1 (en) 2002-03-11
CN1328565A (zh) 2001-12-26
DK1117669T3 (da) 2003-05-26
EP1117669B1 (de) 2003-01-29
GT199900166A (es) 2001-03-21
HUP0103641A2 (hu) 2002-04-29
BR9914097A (pt) 2001-07-31
JP2002525374A (ja) 2002-08-13
IL141959A0 (en) 2002-03-10
TNSN99183A1 (fr) 2005-11-10
PT1117669E (pt) 2003-06-30
AU762757B2 (en) 2003-07-03
DE69905181T2 (de) 2003-06-26
US20010031745A1 (en) 2001-10-18
MA26694A1 (fr) 2004-12-20
ES2192081T3 (es) 2003-09-16
MY121839A (en) 2006-02-28
DE69905181D1 (de) 2003-03-06
AR042368A1 (es) 2005-06-22
NO20011198L (no) 2001-05-28
HUP0103641A3 (en) 2002-10-28
HK1036455A1 (en) 2002-01-04
AU6213899A (en) 2000-04-17
TR200100864T2 (tr) 2001-07-23
GB9821058D0 (en) 1998-11-18
CA2345672A1 (en) 2000-04-06
GC0000174A (en) 2006-03-29
PE20001072A1 (es) 2000-11-20

Similar Documents

Publication Publication Date Title
DE69905181D1 (de) Antivirale purin-derivate
DE60026861D1 (de) Purin-derivate
ATE238336T1 (de) Purin-derivate
IS6196A (is) Púrín afleiður
NO20010743D0 (no) Antivirale indoloksoacetyl-piperazin-derivater
ATE277941T1 (de) Adenosinderivate
ATE314072T1 (de) Antivirale azaindolderivate
PT1296996E (pt) Derivados de purina
NO20005795D0 (no) Antivirale forbindelser
ATE231508T1 (de) Azyklische nukleosidderivate
ATE254126T1 (de) Antivirale nukleosidanaloga
NO20011358L (no) Antivirale kombinasjoner
SI1117669T1 (en) Antiviral purine derivatives
DK1090019T3 (da) Adenosinderivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1117669

Country of ref document: EP

REN Ceased due to non-payment of the annual fee